ExOne GmbH
USPTO PatentsView assignee record - 29 granted patents across 21 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B33Y (Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective ).
The verdict
According to USPTO PatentsView, Exone ranks #10,610 of 49,997 tracked US assignees by granted-patent volume, with 29 patents across 21 technology areas.
- #10,610
- of 49,997 US assignees by volume
- Top 34%
- by Innovation Score (40.9/100)
- 13.4
- avg claims per patent
- +0%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R10610 · Foreign Corporation #10,610 · 29 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL
- GRANTS-SMALL 29 grants
- UPPER-Q #10,610/49,997
- PHOTO-FINISH Eagle Pharmaceuticals
- CPC-FOCUS B33Y · 21 areas
- INNOV-PAR 40.9/100
- CLAIMS-RICH 13.4 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-FLAT +0% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Eagle Pharmaceuticals, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Exone’s 40.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Exone
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Britax Römer… · near
Britax Römer… · near
41 score
- Creator · near
Creator · near
41 score
- ExOne · this assignee
ExOne · this assignee
41 score
- NextLabs · near
NextLabs · near
41 score
- Nissha Printing · near
Nissha Printing · near
41 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Exone's Innovation Score is 40.9/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Exone?
Each dot is one of Exone’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Exone’s own 13.4 claims/patent is at or below the 15.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Exone's grants concentrate
ExOne GmbH is a focused PatentsView assignee: 21 CPC subclasses with 100% of grants classified under B33Y (Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective ). Peak complete grant year is 2019 (5 grants) versus a trough of 1 in 2021. By volume, Exone sits between Eagle Pharmaceuticals, Inc. and Fiat Group Automobiles S.P.A..
Exone's three-year grant acceleration
ExOne GmbH shows 8 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at ExOne's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Eagle Pharmaceuti…
Eagle Pharmaceuticals, Inc.
29 patents
- Controls
Electronic Controls Inc.
29 patents
- Elisa Oyj
Elisa Oyj
29 patents
- Engeneic Molecula…
EnGeneIC Molecular Delivery Pty Ltd
29 patents
- Expensify
Expensify, Inc.
29 patents
- Experian Health
Experian Health, Inc.
29 patents
- FFI Ionix IP
FFI Ionix IP, Inc.
29 patents
- Fiat Group Automo…
Fiat Group Automobiles S.P.A.
29 patents
- Exone ◀
ExOne GmbH
29 patents
What this shows ExOne holds 29 patents at rank #10,609, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near ExOne
By rank, the assignees closest to #10,609 in granted patent volume.
- Eagle Pharmaceuticals, Inc. #10,605 · 29 patents
- Electronic Controls Inc. #10,606 · 29 patents
- Elisa Oyj #10,607 · 29 patents
- EnGeneIC Molecular Delivery Pty Ltd #10,608 · 29 patents
- Expensify, Inc. #10,610 · 29 patents
- Experian Health, Inc. #10,611 · 29 patents
- FFI Ionix IP, Inc. #10,612 · 29 patents
- Fiat Group Automobiles S.P.A. #10,613 · 29 patents
Leaders in B33Y (Additive Manufacturing)
Other assignees with the most granted patents in ExOne's primary technology class.
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for ExOne, neither rank-band nor same-CPC leaders (those blocks stay above). In B33Y (Additive Manufacturing), ExOne ranks #77 of 1,250 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (41 here).
Exone's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
41 Top 34% higher than 66% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 6.9% |
| 2016 | 2 | 6.9% |
| 2017 | 2 | 6.9% |
| 2018 | 3 | 10.3% |
| 2019 | 5 | 17.2% |
| 2020 | 5 | 17.2% |
| 2021 | 1 | 3.4% |
| 2022 | 2 | 6.9% |
| 2023 | 4 | 13.8% |
| 2024 | 2 | 6.9% |
| 2025partial year | 1 | 3.4% |
Which technologies does ExOne GmbH patent most?
Top 15 of 21 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
ExOne GmbH's patent record in context - here's where to go next.
- ExOne GmbH's lead technology class is B33Y (Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective ), 100% of its portfolio - see every assignee active in that class. Explore B33Y
- Ranked #10,610 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare ExOne GmbH against Eagle Pharmaceuticals, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 40.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.